Home Technology Biopharmaceutical Stocks Stemline, Chimerix Climb Midday

Biopharmaceutical Stocks Stemline, Chimerix Climb Midday

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.

Stemline Therapeutics Inc (NASDAQ:STML), Chimerix Inc (NASDAQ:CMRX) and Castlight Health Inc (NYSE:CSLT) are this Tuesday’s top midday gainers. On the losing end are 21Vianet Group Inc (NASDAQ:VNET), Empire Resorts Inc (NASDAQ:NYNY) and Sears Hometown and Outlet Stores Inc (NASDAQ:SHOS).

Make sure you sign up for our free newsletter

Stemline, Chimerix Climb

Stemline Therapeutics Inc (NASDAQ:STML) climbed +15.19% midday today. The biopharmaceutical services provider, a Farallon Capital holding, has gained +23.78% in the past month and has been generating its fair share of buzz among Wall Street analysts as of late.

[drizzle]

The share price of Chimerix Inc (NASDAQ:CMRX) increased +10.77% early in the day thanks to promising data on one of its antiviral drugs and a new buy rating from Cantor Fitzgerald. The biopharmaceutical company is up +87.29% year-to-date.

Taking the third and final spot on today’s list of midday gainers is Castlight Health Inc (NYSE:CSLT), up +6.59%. In the Tiger Global portfolio since the first quarter of this year, Castlight is climbing ahead of its lock-up period expiration, which is set for tomorrow.

SHOS Takes a Dive Following Results Release

21Vianet Group Inc (NASDAQ:VNET) reached midday down -9.16%, its price declining despite the news that it will partner with Huawei to launch China’s largest commercial SDN network. VNET has had a relatively strong year, its price up +6.72% in 2014. Farallon Capital and George Soros have positions in the company.

Empire Resorts Inc (NASDAQ:NYNY) dipped -7.33% early in the day this Tuesday. The gaming and resort management company has declined -36.65% over the past three months.

Finally, the share price of Sears Hometown and Outlet Stores Inc (NASDAQ:SHOS) declined -6.81% on the heels the release of its quarterly results report this morning. Operating income decreased to $5.8 million in Q2, and EPS fell to $0.15%. Billionaire Edward Lampert holds nearly 5.8 million SHOS shares.

Make sure you sign up for our free newsletter

[/drizzle]
Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski5 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...